Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The increasing companion animal population, growing prevalence of arthritis, rising risk factors for the disease, supportive awareness programs initiated by governments, and strategies implemented by key companies are some of the key factors driving the market.
This report aims to provide a comprehensive presentation of the global market for Companion Animal Arthritis study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Companion Animal Arthritis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Companion Animal Arthritis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Osteoarthritis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Companion Animal Arthritis include Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC., Vetoquinol, NexGen Pharmaceuticals and Norbrook and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Companion Animal Arthritis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Companion Animal Arthritis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Companion Animal Arthritis Market Segment Percentages, by Type, 2021 (%)
Osteoarthritis
Other Arthritis
Global Companion Animal Arthritis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Companion Animal Arthritis Market Segment Percentages, by Application, 2021 (%)
Dogs
Cats
Others
Global Companion Animal Arthritis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Companion Animal Arthritis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Companion Animal Arthritis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Companion Animal Arthritis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Virbac
Elanco
Boehringer Ingelheim International GmbH
Ceva
Dechra Pharmaceuticals PLC.
Vetoquinol
NexGen Pharmaceuticals
Norbrook
Eltech K-Laser s.r.l.
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Companion Animal Arthritis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Companion Animal Arthritis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Companion Animal Arthritis Overall Market Size
2.1 Global Companion Animal Arthritis Market Size: 2021 VS 2028
2.2 Global Companion Animal Arthritis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Companion Animal Arthritis Players in Global Market
3.2 Top Global Companion Animal Arthritis Companies Ranked by Revenue
3.3 Global Companion Animal Arthritis Revenue by Companies
3.4 Top 3 and Top 5 Companion Animal Arthritis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Companion Animal Arthritis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Animal Arthritis Players in Global Market
3.6.1 List of Global Tier 1 Companion Animal Arthritis Companies
3.6.2 List of Global Tier 2 and Tier 3 Companion Animal Arthritis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Companion Animal Arthritis Market Size Markets, 2021 & 2028
4.1.2 Osteoarthritis
4.1.3 Other Arthritis
4.2 By Type - Global Companion Animal Arthritis Revenue & Forecasts
4.2.1 By Type - Global Companion Animal Arthritis Revenue, 2017-2022
4.2.2 By Type - Global Companion Animal Arthritis Revenue, 2023-2028
4.2.3 By Type - Global Companion Animal Arthritis Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Companion Animal Arthritis Market Size, 2021 & 2028
5.1.2 Dogs
5.1.3 Cats
5.1.4 Others
5.2 By Application - Global Companion Animal Arthritis Revenue & Forecasts
5.2.1 By Application - Global Companion Animal Arthritis Revenue, 2017-2022
5.2.2 By Application - Global Companion Animal Arthritis Revenue, 2023-2028
5.2.3 By Application - Global Companion Animal Arthritis Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Companion Animal Arthritis Market Size, 2021 & 2028
6.2 By Region - Global Companion Animal Arthritis Revenue & Forecasts
6.2.1 By Region - Global Companion Animal Arthritis Revenue, 2017-2022
6.2.2 By Region - Global Companion Animal Arthritis Revenue, 2023-2028
6.2.3 By Region - Global Companion Animal Arthritis Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Companion Animal Arthritis Revenue, 2017-2028
6.3.2 US Companion Animal Arthritis Market Size, 2017-2028
6.3.3 Canada Companion Animal Arthritis Market Size, 2017-2028
6.3.4 Mexico Companion Animal Arthritis Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Companion Animal Arthritis Revenue, 2017-2028
6.4.2 Germany Companion Animal Arthritis Market Size, 2017-2028
6.4.3 France Companion Animal Arthritis Market Size, 2017-2028
6.4.4 U.K. Companion Animal Arthritis Market Size, 2017-2028
6.4.5 Italy Companion Animal Arthritis Market Size, 2017-2028
6.4.6 Russia Companion Animal Arthritis Market Size, 2017-2028
6.4.7 Nordic Countries Companion Animal Arthritis Market Size, 2017-2028
6.4.8 Benelux Companion Animal Arthritis Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Companion Animal Arthritis Revenue, 2017-2028
6.5.2 China Companion Animal Arthritis Market Size, 2017-2028
6.5.3 Japan Companion Animal Arthritis Market Size, 2017-2028
6.5.4 South Korea Companion Animal Arthritis Market Size, 2017-2028
6.5.5 Southeast Asia Companion Animal Arthritis Market Size, 2017-2028
6.5.6 India Companion Animal Arthritis Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Companion Animal Arthritis Revenue, 2017-2028
6.6.2 Brazil Companion Animal Arthritis Market Size, 2017-2028
6.6.3 Argentina Companion Animal Arthritis Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Companion Animal Arthritis Revenue, 2017-2028
6.7.2 Turkey Companion Animal Arthritis Market Size, 2017-2028
6.7.3 Israel Companion Animal Arthritis Market Size, 2017-2028
6.7.4 Saudi Arabia Companion Animal Arthritis Market Size, 2017-2028
6.7.5 UAE Companion Animal Arthritis Market Size, 2017-2028
7 Players Profiles
7.1 Zoetis
7.1.1 Zoetis Corporate Summary
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Companion Animal Arthritis Major Product Offerings
7.1.4 Zoetis Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.1.5 Zoetis Key News
7.2 Virbac
7.2.1 Virbac Corporate Summary
7.2.2 Virbac Business Overview
7.2.3 Virbac Companion Animal Arthritis Major Product Offerings
7.2.4 Virbac Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.2.5 Virbac Key News
7.3 Elanco
7.3.1 Elanco Corporate Summary
7.3.2 Elanco Business Overview
7.3.3 Elanco Companion Animal Arthritis Major Product Offerings
7.3.4 Elanco Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.3.5 Elanco Key News
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Corporate Summary
7.4.2 Boehringer Ingelheim International GmbH Business Overview
7.4.3 Boehringer Ingelheim International GmbH Companion Animal Arthritis Major Product Offerings
7.4.4 Boehringer Ingelheim International GmbH Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.4.5 Boehringer Ingelheim International GmbH Key News
7.5 Ceva
7.5.1 Ceva Corporate Summary
7.5.2 Ceva Business Overview
7.5.3 Ceva Companion Animal Arthritis Major Product Offerings
7.5.4 Ceva Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.5.5 Ceva Key News
7.6 Dechra Pharmaceuticals PLC.
7.6.1 Dechra Pharmaceuticals PLC. Corporate Summary
7.6.2 Dechra Pharmaceuticals PLC. Business Overview
7.6.3 Dechra Pharmaceuticals PLC. Companion Animal Arthritis Major Product Offerings
7.6.4 Dechra Pharmaceuticals PLC. Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.6.5 Dechra Pharmaceuticals PLC. Key News
7.7 Vetoquinol
7.7.1 Vetoquinol Corporate Summary
7.7.2 Vetoquinol Business Overview
7.7.3 Vetoquinol Companion Animal Arthritis Major Product Offerings
7.7.4 Vetoquinol Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.7.5 Vetoquinol Key News
7.8 NexGen Pharmaceuticals
7.8.1 NexGen Pharmaceuticals Corporate Summary
7.8.2 NexGen Pharmaceuticals Business Overview
7.8.3 NexGen Pharmaceuticals Companion Animal Arthritis Major Product Offerings
7.8.4 NexGen Pharmaceuticals Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.8.5 NexGen Pharmaceuticals Key News
7.9 Norbrook
7.9.1 Norbrook Corporate Summary
7.9.2 Norbrook Business Overview
7.9.3 Norbrook Companion Animal Arthritis Major Product Offerings
7.9.4 Norbrook Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.9.5 Norbrook Key News
7.10 Eltech K-Laser s.r.l.
7.10.1 Eltech K-Laser s.r.l. Corporate Summary
7.10.2 Eltech K-Laser s.r.l. Business Overview
7.10.3 Eltech K-Laser s.r.l. Companion Animal Arthritis Major Product Offerings
7.10.4 Eltech K-Laser s.r.l. Companion Animal Arthritis Revenue in Global Market (2017-2022)
7.10.5 Eltech K-Laser s.r.l. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Companion Animal Arthritis Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|